| Identification | Back Directory | [Name]
OXELADIN CITRATE | [CAS]
52432-72-1 | [Synonyms]
Oxeladine
er,citrate(1:1)
oxeladinecitrate
OXELADIN CITRATE
OXELADIN CITRATE SALT
OXELADINCITRATE(FORR&DONLY)
oxeladin dihydrogen citrate
Oxeladin hydrogen citrate CRS
Oxeladincitrate/Oxeladinidihydrogencitras
alpha,alpha-diethyl-benzeneaceticaci2-(2-(diethylamino)ethoxy)ethylest
butyricacid,2-ethyl-2-phenyl-,2-(2-(diethylamino)ethoxy)ethylester,citrate
2-(2-(Diethylamino)ethoxy)ethyl 2-ethyl-2-phenylbutanoate 2-hydroxypropane-1,2,3-tricarboxylate
2-[2-(diethylamino)ethoxy]ethyl 2-ethyl-2-phenylbutanoate,2-hydroxypropane-1,2,3-tricarboxylic acid
2-[2-(Diethylamino)ethoxy]ethyl 2-ethyl-2-phenylbutanoate dihydrogen 2-hydroxypropane-1,2,3-tricarboxylate. | [EINECS(EC#)]
257-910-8 | [Molecular Formula]
C26H41NO10 | [MDL Number]
MFCD00027040 | [MOL File]
52432-72-1.mol | [Molecular Weight]
527.6 |
| Chemical Properties | Back Directory | [Appearance]
White or almost white, crystalline powder. | [Melting point ]
90-91° | [storage temp. ]
Inert atmosphere,Room Temperature | [solubility ]
Freely soluble in water, slightly to very slightly soluble in ethyl acetate. | [form ]
neat | [color ]
White to off-white | [Major Application]
forensics and toxicology
pharmaceutical (small molecule) | [InChIKey]
KVKJFNUGVOFNGU-UHFFFAOYSA-N | [SMILES]
OC(=O)CC(O)(CC(O)=O)C(O)=O.CCN(CC)CCOCCOC(=O)C(CC)(CC)c1ccccc1 | [Uses]
Cough suppressant. |
| Hazard Information | Back Directory | [Chemical Properties]
White or almost white, crystalline powder. | [in vivo]
Oxeladin (135 mg/kg/d, p.o. for 11 d) reduces the extent of infarct expansion in the subacute phase of stroke in rats[1].
| Animal Model: | Middle cerebral artery occlusion model rats[1] | | Dosage: | 135 mg/kg/day | | Administration: | MCAO for 2 d, then Oral gavage (p.o.) for 11 d | | Result: | Significantly improved neurological function on days 3, 7, and 14 following MCAO, decreased final extent of infarct after 14 days. Increased the amount of mature brain-derived neurotrophic factor in the cerebral cortex 2, 6, and 24 h after single oral dose. |
|
| Safety Data | Back Directory | [Hazard Codes ]
T | [Risk Statements ]
23/24/25 | [Safety Statements ]
36/37/39-45 | [RIDADR ]
UN 2811 6.1/PG 3
| [WGK Germany ]
3
| [RTECS ]
ET1760000
| [Storage Class]
6.1C - Combustible acute toxic Cat.3
toxic compounds or compounds which causing chronic effects | [Hazard Classifications]
Acute Tox. 3 Dermal
Acute Tox. 3 Inhalation
Acute Tox. 3 Oral |
|
| Company Name: |
LGM Pharma
|
| Tel: |
1-(800)-881-8210 |
| Website: |
www.lgmpharma.com |
| Company Name: |
Spectrum Chemical Manufacturing Corp.
|
| Tel: |
021-021-021-67601398-809-809-809 15221380277 |
| Website: |
www.spectrumchemical.com/oa_html/index.jsp?minisite=10020&respid=22372&language=us |
|